Related Experiment Videos

Should all diabetic patients take ACE inhibitors, even those without proteinuria?

¹Department of Endocrinology, Cleveland Clinic, USA.

Cleveland Clinic Journal of Medicine

|April 13, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.

Diabetes, obesity & metabolism·2016

Similar HbA1c reduction and hypoglycaemia with variable- vs fixed-time dosing of basal insulin peglispro in type 1 diabetes: IMAGINE 7 study.

Diabetes, obesity & metabolism·2016

Risk factors for 30-day readmission following hypoglycemia-related emergency room and inpatient admissions.

BMJ open diabetes research & care·2016

Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011.

Journal of diabetes and its complications·2015

Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy.

International journal of clinical practice·2012

Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting.

Diabetes, obesity & metabolism·2012

See all related articles